Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Explore which real-world use cases BTC or ETH enables today. This quick intro highlights practical applications and adoption trends to help you decide where to focus.
28,607 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
A hypothetical look at britain's warren buffett pared nearly every position in a $13 billion portfolio during the fir...
Two high-flying stocks with more upside may fit a patient investor's long-term plan. This article dives into NVIDIA a...
Learn practical, battle-tested steps to maximize credit card rewards. This guide breaks down how to choose cards, sta...
A single quantum computing stock could reshape your portfolio like Palantir did for AI software. This guide breaks do...
As SuRo Capital releases its Q4 2025 results, investors need a clear playbook. This deep dive breaks down the key met...
SpaceX has captured headlines with a blockbuster IPO, but the stock has cooled. This article breaks down how historic...
Buffett just showed a bold faith in AI by backing a leading tech name. Here are three clear reasons Warren Buffett's ...
When the Fed signals a policy shift, traders rush to position. This article dives into the appeal of a 3X Financial B...
Micron stock jumped today as traders weighed demand signals, supply dynamics, and broader market strength. This artic...
Upstart is pivoting beyond personal loans into new lending frontiers. This in-depth guide breaks down the big move, h...